(-)-Fenchone Ameliorates TNBS-Induced Colitis in Rats via Antioxidant, Immunomodulatory, and Cytoprotective Mechanisms

(-)-Fenchone Ameliorates TNBS-Induced Colitis in Rats via Antioxidant, Immunomodulatory, and Cytoprotective Mechanisms

Background: (-)-Fenchone is a bicyclic monoterpene present in the plant species <i>Foeniculum vulgare</i> Mill, <i>Thuja occidentalis</i> L. (tuja), and <i>Lavandula stoechas</i> (lavender). These plants have therapeutic value in the treatment of intestinal disord...

Full description

Saved in:
Bibliographic Details
Main Authors: Maria Elaine Cristina Araruna, Edvaldo Balbino Alves Júnior, Catarina Alves de Lima Serafim, Matheus Marley Bezerra Pessoa, Michelle Liz de Souza Pessôa, Vitória Pereira Alves, Marianna Vieira Sobral, Marcelo Sobral da Silva, Adriano Francisco Alves, Maria Carolina de Paiva Sousa, Aurigena Antunes Araújo, Leônia Maria Batista
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Pharmaceuticals
Subjects:
(-)-fenchone
ulcerative colitis
antioxidant
immunomodulatory
cytoprotection
Online Access:https://www.mdpi.com/1424-8247/18/1/18
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: (-)-Fenchone is a bicyclic monoterpene present in the plant species <i>Foeniculum vulgare</i> Mill, <i>Thuja occidentalis</i> L. (tuja), and <i>Lavandula stoechas</i> (lavender). These plants have therapeutic value in the treatment of intestinal disorders. Aim: To evaluate intestinal anti-inflammatory activity in an acute and chronic trinitrobenzene sulphonic acid (TNBS)-induced colitis model in rats. Methods: Intestinal anti-inflammatory effects were assessed using the acute and chronic TNBS-induced colitis model in rats. The mechanisms were evaluated from colonic tissue fragments of the acute and chronic models. Results: Oral administration of the (-)-fenchone (37.5–300 mg/kg) acute phase or (150 mg/kg) (<i>p</i> < 0.001) chronic phase reduced the macroscopic lesion score, ulcerative area, intestinal weight/length ratio, and diarrheal index in TNBS-treated animals. At a dose of 150 mg/kg, the acute and chronic phase decreased malondialdehyde (MDA) and myeloperoxidase (MPO) (<i>p</i> < 0.001), restored glutathione (GSH) levels and superoxide dismutase (SOD) (<i>p</i> < 0.001), decreased immunomarking for factor nuclear kappa B (NF-κB) and levels of interleukin (IL)-1 and tumor necrosis factor α (TNF-α), and maintained IL-10 and TGF-β basal levels. Furthermore, increased immunostaining for zonula occludens 1 (ZO-1) was observed. Conclusions: (-)-fenchone has intestinal anti-inflammatory activity related to cytoprotection of the intestinal barrier, as well as antioxidant and immunomodulatory effects.
ISSN:1424-8247

Similar Items